Company / Return on Assets (ROA)
Alaunos Therapeutics, Inc. Return on Assets (ROA) History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-157.8%
FY2025
5-year range
-1275.5% / -84.3%
FY2021-FY2025
Trend
+87.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2025 after 4 years of decline, reaching -157.8%.
Based on SEC 10-K filings.
-157.8% in FY2025 with a 5-year CAGR of -121.4%.
Improved from -456.6% to -157.8% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -36.5pp
- 5-Year Change
- -121.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 87.6% year-over-year.
- Peak return on assets (roa) was recorded in FY2012.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.79 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -157.8% | +87.6% |
| FY2024 | -1275.5% | -179.3% |
| FY2023 | -456.6% | -276.5% |
| FY2022 | -121.3% | -43.8% |
| FY2021 | -84.3% | -132.3% |
| FY2020 | -36.3% | +27.1% |
| FY2019 | -49.8% | +71.4% |
| FY2018 | -173.9% | -2092.9% |
| FY2013 | -7.9% | -4073.7% |
| FY2012 | -0.2% | -26.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026